BLUE STAR GOLD CORP (BAU.CA) Fundamental Analysis & Valuation

TSX-V:BAU • CA09607B2021

Current stock price

0.22 CAD
+0.01 (+2.33%)
Last:

This BAU.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. BAU.CA Profitability Analysis

1.1 Basic Checks

  • BAU had negative earnings in the past year.
  • BAU had a negative operating cash flow in the past year.
  • BAU had negative earnings in each of the past 5 years.
  • BAU had a negative operating cash flow in each of the past 5 years.
BAU.CA Yearly Net Income VS EBIT VS OCF VS FCFBAU.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M

1.2 Ratios

Industry RankSector Rank
ROA -106.35%
ROE -167.77%
ROIC N/A
ROA(3y)-71.56%
ROA(5y)-49.52%
ROE(3y)-178.1%
ROE(5y)-118.7%
ROIC(3y)N/A
ROIC(5y)N/A
BAU.CA Yearly ROA, ROE, ROICBAU.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

1.3 Margins

  • BAU does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BAU.CA Yearly Profit, Operating, Gross MarginsBAU.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. BAU.CA Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for BAU has been increased compared to 1 year ago.
  • BAU has more shares outstanding than it did 5 years ago.
  • BAU has a worse debt/assets ratio than last year.
BAU.CA Yearly Shares OutstandingBAU.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BAU.CA Yearly Total Debt VS Total AssetsBAU.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

  • BAU has an Altman-Z score of -4.51. This is a bad value and indicates that BAU is not financially healthy and even has some risk of bankruptcy.
  • The Debt to FCF ratio of BAU is 1.87, which is an excellent value as it means it would take BAU, only 1.87 years of fcf income to pay off all of its debts.
  • A Debt/Equity ratio of 0.43 indicates that BAU is not too dependend on debt financing.
  • Although BAU's pure debt/equity ratio does not look good, it has limited outstanding debt compared to the Free Cash Flow. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 1.87
Altman-Z -4.51
ROIC/WACCN/A
WACCN/A
BAU.CA Yearly LT Debt VS Equity VS FCFBAU.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

  • BAU has a Current Ratio of 4.40. This indicates that BAU is financially healthy and has no problem in meeting its short term obligations.
  • BAU has a Quick Ratio of 4.40. This indicates that BAU is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 4.4
Quick Ratio 4.4
BAU.CA Yearly Current Assets VS Current LiabilitesBAU.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. BAU.CA Growth Analysis

3.1 Past

  • The earnings per share for BAU have decreased strongly by -26.70% in the last year.
EPS 1Y (TTM)-26.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%84.5%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. BAU.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • BAU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BAU.CA Price Earnings VS Forward Price EarningsBAU.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 30.5
EV/EBITDA N/A
BAU.CA Per share dataBAU.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 -0.04 -0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BAU.CA Dividend Analysis

5.1 Amount

  • No dividends for BAU!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BAU.CA Fundamentals: All Metrics, Ratios and Statistics

BLUE STAR GOLD CORP

TSX-V:BAU (4/8/2026, 7:00:00 PM)

0.22

+0.01 (+2.33%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)02-25
Earnings (Next)04-15
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners69.95%
Ins Owner ChangeN/A
Market Cap35.21M
Revenue(TTM)N/A
Net Income(TTM)-8.34M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF 30.5
P/OCF N/A
P/B 7.08
P/tB 7.08
EV/EBITDA N/A
EPS(TTM)-0.08
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.01
FCFY3.28%
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -106.35%
ROE -167.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-71.56%
ROA(5y)-49.52%
ROE(3y)-178.1%
ROE(5y)-118.7%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 1.87
Debt/EBITDA N/A
Cap/Depr 1454.14%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.4
Quick Ratio 4.4
Altman-Z -4.51
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)1193.19%
Cap/Depr(5y)6874.53%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%84.5%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-39.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y124.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-158.43%
OCF growth 3YN/A
OCF growth 5YN/A

BLUE STAR GOLD CORP / BAU.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BLUE STAR GOLD CORP (BAU.CA) stock?

ChartMill assigns a fundamental rating of 1 / 10 to BAU.CA.


Can you provide the valuation status for BLUE STAR GOLD CORP?

ChartMill assigns a valuation rating of 0 / 10 to BLUE STAR GOLD CORP (BAU.CA). This can be considered as Overvalued.


How profitable is BLUE STAR GOLD CORP (BAU.CA) stock?

BLUE STAR GOLD CORP (BAU.CA) has a profitability rating of 0 / 10.